Heska Third Quarter 2022 Financial Results and Earnings Call Scheduled for November 8, 2022
Heska Corporation (NASDAQ: HSKA) will announce its Q3 2022 financial results on November 8, 2022, before market opening. An earnings call is scheduled for 9 a.m. MT / 11 a.m. ET the same day. Investors can participate by dialing in or via live webcast on the company's investor relations site. A replay of the call will be available starting at 2 p.m. ET on November 8.
The company specializes in advanced veterinary diagnostics and has a diverse product portfolio spanning diagnostics and healthcare solutions.
- Pending Q3 2022 earnings report could provide insights into revenue growth.
- Scheduled earnings call allows for direct engagement with investors.
- None.
LOVELAND, Colo., Oct. 18, 2022 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA; "Heska" or the "Company"), a leading global provider of advanced veterinary diagnostic and specialty solutions, will report its third quarter 2022 financial performance in a press release before the market opens on Tuesday, November 8, 2022. The Company will also host an earnings call at 9 a.m. MT / 11 a.m. ET to discuss the results.
To access the conference call:
From within the United States, please dial 1-800-239-9838
From outside of the United States, please dial 1-323-794-2551
Reference Conference ID: 7035658
The earnings call will be webcast live from the Company's investor relations website at: Heska Corporation Third Quarter 2022 Earnings Call Webcast.
A telephonic replay will be available at 2 p.m. ET on November 8th through 11:59 p.m. ET on November 22, 2022 and the webcast will be archived on the Company's website for 90 days.
To access the replay by telephone:
From within the United States, please dial 1-844-512-2921
From outside the United States, please dial 1-412-317-6671
Reference Replay Pin Number: 7035658
About Heska
Heska Corporation (NASDAQ: HSKA) manufactures, develops and sells advanced veterinary diagnostics, informatics, and specialty healthcare solutions through its two business segments: North America and International. Both segments include Point of Care Lab testing instruments and consumables, digital imaging products, software and services, data services, allergy testing and immunotherapy, and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. The North America segment also includes private label vaccine and pharmaceutical production for third-parties, primarily for herd animal health. For more information, please visit www.heska.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/heska-third-quarter-2022-financial-results-and-earnings-call-scheduled-for-november-8-2022-301651800.html
SOURCE Heska Corporation
FAQ
When will Heska report its Q3 2022 earnings?
What time is the Heska earnings call scheduled for?
How can I access the Heska earnings call?